An optimized zebrafish obesogenic test protocol with an artificial intelligence-based analysis software for screening obesogens and anti-obesogens
Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white a...
Saved in:
Published in | Biology methods and protocols Vol. 10; no. 1; p. bpaf052 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
2025
|
Subjects | |
Online Access | Get full text |
ISSN | 2396-8923 2396-8923 |
DOI | 10.1093/biomethods/bpaf052 |
Cover
Loading…
Abstract | Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software (ZOTAS) was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments. |
---|---|
AbstractList | Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for
staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative
assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments. Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments.Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments. Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software (ZOTAS) was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments. Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments. Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments. |
Author | Al Kassir, Sara Mercé, Théo Bourcier, Laure M Soares, Magalie Knoll-Gellida, Anja Podechard, Normand Babin, Patrick J Pedemay, Sandra Le Mentec, Hélène |
Author_xml | – sequence: 1 givenname: Sara surname: Al Kassir fullname: Al Kassir, Sara – sequence: 2 givenname: Théo surname: Mercé fullname: Mercé, Théo – sequence: 3 givenname: Sandra surname: Pedemay fullname: Pedemay, Sandra – sequence: 4 givenname: Laure M surname: Bourcier fullname: Bourcier, Laure M – sequence: 5 givenname: Magalie surname: Soares fullname: Soares, Magalie – sequence: 6 givenname: Hélène surname: Le Mentec fullname: Le Mentec, Hélène – sequence: 7 givenname: Normand surname: Podechard fullname: Podechard, Normand – sequence: 8 givenname: Anja surname: Knoll-Gellida fullname: Knoll-Gellida, Anja – sequence: 9 givenname: Patrick J orcidid: 0000-0002-7411-2297 surname: Babin fullname: Babin, Patrick J |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40799311$$D View this record in MEDLINE/PubMed https://hal.science/hal-05162357$$DView record in HAL |
BookMark | eNpdkstuFDEQRS0URELID7BAltjAokn50a8VGkVAkEZiA2vLdtvTjrrtxvYkSj6DL8bDDEPIylb5-Fbp1n2JTnzwBqHXBD4Q6NmlcmE2eQxDulSLtFDTZ-iMsr6pup6yk0f3U3SR0g0AkI7XBMgLdMqh7XtGyBn6tfI4LNnN7sEM-MGoKK1LIw7KpLAx3mmcTcp4iSEHHSZ85_KIpccyZmeddnLCzmczTa7Q2lRKpiIkvZzuk0s4BZvvZDTYhoiTjqZI-s1RPhVyR2dXHUuv0HMrp2QuDuc5-vH50_er62r97cvXq9W60owxWjHVEN5b1cBQd72iHVdcMVuzltRgSQetrhtNzWBVp4xqqBxAwdBJoC2VkrFz9HGvu2zVbAZtfI5yEkt0s4z3Ikgn_n_xbhSbcCsIZZwB8KLwfq8wPvl3vVqLXQ1q0lBWt7eksO8O3WL4uS2WitklXXyT3oRtEqzsi1DC276gb5-gN2Ebi6N_qK4FwnlTqDePxz_2_7vbAtA9oGNIKRp7RAiIXYbEvwyJQ4bYb2WdwL8 |
ContentType | Journal Article |
Copyright | The Author(s) 2025. Published by Oxford University Press. The Author(s) 2025. Published by Oxford University Press. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Attribution - NonCommercial The Author(s) 2025. Published by Oxford University Press. 2025 |
Copyright_xml | – notice: The Author(s) 2025. Published by Oxford University Press. – notice: The Author(s) 2025. Published by Oxford University Press. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Attribution - NonCommercial – notice: The Author(s) 2025. Published by Oxford University Press. 2025 |
DBID | AAYXX CITATION NPM 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ HCIFZ LK8 M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI 7X8 1XC 5PM |
DOI | 10.1093/biomethods/bpaf052 |
DatabaseName | CrossRef PubMed ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection (ProQuest) ProQuest Central Natural Science Collection (ProQuest) ProQuest One ProQuest Central ProQuest Central Student SciTech Premium Collection (ProQuest) Biological Sciences Biological science database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Biological Science Collection ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Biological Science Database ProQuest SciTech Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Academic UKI Edition Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2396-8923 |
ExternalDocumentID | PMC12343004 oai_HAL_hal_05162357v1 40799311 10_1093_biomethods_bpaf052 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; |
GroupedDBID | 0R~ 53G AAFWJ AAPXW AAVAP AAYXX ABDBF ABEJV ABGNP ABPTD ABXVV ACGFS ACUHS AENZO AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AMNDL AVWKF BAYMD BBNVY BENPR BHPHI CCPQU CITATION EBS ESX GROUPED_DOAJ H13 HCIFZ IAO IHR ISR KSI M7P M~E O9- OAWHX OJQWA OK1 PEELM PHGZM PHGZT PIMPY PQGLB RPM TOX EJD ITC NPM 8FE 8FH ABUWG AZQEC DWQXO GNUQQ LK8 PKEHL PQEST PQQKQ PQUKI PUEGO 7X8 1XC 5PM |
ID | FETCH-LOGICAL-c3332-3b6149fb60d589b284b4b3f537150f1807c56c2edfb8beb62ad0b0d8a0272aa33 |
IEDL.DBID | BENPR |
ISSN | 2396-8923 |
IngestDate | Thu Aug 21 18:27:57 EDT 2025 Thu Aug 28 06:24:09 EDT 2025 Sat Aug 23 12:16:07 EDT 2025 Wed Aug 27 01:32:29 EDT 2025 Sun Aug 17 02:25:10 EDT 2025 Thu Aug 14 00:06:29 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | endocrine disruptors ZOTAS adipose tissue zebrafish ZOT obesity anti-obesogens obesogens Ecology Biology Test (biology) Computer science Medicine Pathology Gene Alternative medicine Genetics Software Protocol (science) Artificial intelligence Operating system |
Language | English |
License | https://creativecommons.org/licenses/by-nc/4.0 The Author(s) 2025. Published by Oxford University Press. Attribution - NonCommercial: http://creativecommons.org/licenses/by-nc This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3332-3b6149fb60d589b284b4b3f537150f1807c56c2edfb8beb62ad0b0d8a0272aa33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-7411-2297 0000-0002-3687-1778 0000-0002-2638-3180 |
OpenAccessLink | https://www.proquest.com/docview/3238701446?pq-origsite=%requestingapplication% |
PMID | 40799311 |
PQID | 3238701446 |
PQPubID | 7121356 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_12343004 hal_primary_oai_HAL_hal_05162357v1 proquest_miscellaneous_3239121479 proquest_journals_3238701446 pubmed_primary_40799311 crossref_primary_10_1093_biomethods_bpaf052 |
PublicationCentury | 2000 |
PublicationDate | 2025-00-00 |
PublicationDateYYYYMMDD | 2025-01-01 |
PublicationDate_xml | – year: 2025 text: 2025-00-00 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Biology methods and protocols |
PublicationTitleAlternate | Biol Methods Protoc |
PublicationYear | 2025 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
SSID | ssj0001845101 |
Score | 2.2786677 |
Snippet | Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the... |
SourceID | pubmedcentral hal proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | bpaf052 |
SubjectTerms | Adipocytes Adipose tissue Artificial intelligence Body fat Contaminants Danio rerio Deep learning Endocrine disruptors Fluorescence microscopy High-throughput screening Larvae Life Sciences Methods Obesity Toxicants |
Title | An optimized zebrafish obesogenic test protocol with an artificial intelligence-based analysis software for screening obesogens and anti-obesogens |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40799311 https://www.proquest.com/docview/3238701446 https://www.proquest.com/docview/3239121479 https://hal.science/hal-05162357 https://pubmed.ncbi.nlm.nih.gov/PMC12343004 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZoKyQuqLxTSmUQN2RtYufhnKotarVCUBBqpb1FfmpzIFmabRH9GfziziTebBckLjk4o8TKTGa-GdvfEPLeAwYotNOMG29ZaoxmmvuM6cJzaR13tm_n8-U8n12mn-bZPBTcurCtcu0Te0dtW4M18omA2FIg_M-Plz8Zdo3C1dXQQmOH7IELlpB87Z2cnn_7vqmyyBSNLpyWgex90p9qx97M3UQvFUyVb0WknQXuh_wXbP69Z_JeEDrbJ48DeqTTQd1PyAPXPCUPh36Sv5-RP9OGtuADftS3ztJbXBP2dbegrXZdC5ZSGwrIckWRnKEFC6BYhaWqoWg_A5UEre9xdDKMcRYEBuIS2oHP_qWuHAWkS8HfQA4MkW98fAeSKL2q2Tj0nFyenV58nLHQdIEZIQRnQkPALr3OY5vJUkP00qkWPhMFQEefyLgwWW5Ah15L0HHOlY11bKWC_JYrJcQLstu0jXtFqMxs4ZW0tuSYRvLSOrALnphYFCIzaUQ-rD98tRy4NaphTVxUGzVVQU0ReQe6GQWRFns2_VzhGDiWHGl7bpKIHK5VV4Wfsas2phORt-Nt-I1wbUQ1rr3uZcoEezaVEXk5aHp8FeS8gOISeLjcsoGtuWzfaepFT9UNuCBFTrOD_8_rNXnEsa9wX9o5JLurq2v3BsDOSh8Fiz7qiwVwvfg6vwMGVwm- |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VrRBcEP-kFDAITsjaxM7vAaEFWm3pdoVQK_WWxrGtzYFk22yp2sfgQXhGZpJstgsSt16TUeJkPs98M7ZnAN5a5ACRMoqL3Gru57niStiAq8iKWBthdNPO52Aajo_8r8fB8Qb8Xp6FoW2VS5vYGGpd5ZQjH0r0LRHR__Dj_JRT1yhaXV220GhhsW8uLzBkqz_sfUH9vhNid-fw85h3XQV4LqUUXCr0SIlVoauDOFFonpWvpA1khNzIerEb5UGY4yCtivEjQpFpV7k6zjCAE1lGCVA0-Zu-xFBmAJufdqbfvq-yOrFPIO9O57iJHDan6KkXdD1U8wx_jVjzgLdmtP_yX3L79x7Na05v9z7c69gqG7XwegAbpnwIt9v-lZeP4NeoZBXanB_FldHsitagbVHPWKVMXSEyi5whk10wKgZRIeIYZX1ZVjLCa1u6ghXXaoJy8qkaBdpCKaxGH3GRnRmGzJqhfcOYGz1t__gaJUl6UfD-0mM4uhF1PIFBWZXmGbA40JHNYq0TQWGrSLRBHAovd2Ukg9x34P3yx6fztpZH2q7By3SlprRTkwNvUDe9IJXhHo8mKV1DQxZSmaCfngPbS9Wl3eSv0xVUHXjd38ZpS2sxWWmq80Ym8ahHVOLA01bT_aswxkbW6OHD4zUMrI1l_U5ZzJrS4MhDfKqhtvX_cb2CO-PDg0k62ZvuP4e7gnoaN2mlbRgszs7NCyRaC_WyQzeDk5ueUH8AkfdD-A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+optimized+zebrafish+obesogenic+test+protocol+with+an+artificial+intelligence-based+analysis+software+for+screening+obesogens+and+anti-obesogens&rft.jtitle=Biology+methods+and+protocols&rft.au=Al+Kassir%2C+Sara&rft.au=Merc%C3%A9%2C+Th%C3%A9o&rft.au=Pedemay%2C+Sandra&rft.au=Bourcier%2C+Laure+M&rft.date=2025&rft.issn=2396-8923&rft.eissn=2396-8923&rft.volume=10&rft.issue=1&rft.spage=bpaf052&rft_id=info:doi/10.1093%2Fbiomethods%2Fbpaf052&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2396-8923&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2396-8923&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2396-8923&client=summon |